Polysarcosine (pSar) Lipids

• Inquiry

What is Polysarcosine?

Polysarcosine (pSar) represents a non-ionic polypeptoid that demonstrates hydrophilic properties as it originates from the polymerization of sarcosine which is an N-methylated glycine. This biomaterial demonstrates outstanding biocompatibility along with stealth capabilities and protein adsorption resistance. Polysarcosine stands out from traditional polymeric stabilizers like polyethylene glycol (PEG) as a naturally derived option that delivers better pharmacokinetic performance and lowers immunogenic response. Polysarcosine has become a valuable material for biomedical applications because of its distinct physicochemical properties which find specific use in nanoparticle engineering and lipid-based drug delivery systems.

Polysarcosine Structure

At a molecular level, polysarcosine is characterized by a repeating sarcosine backbone, which imparts:

• Hydrophilicity and Solubility: The polymer is highly water-soluble, enhancing the stability of nanocarriers in physiological environments.
• Amide Linkages: The peptide bonds in pSar ensure enzymatic degradability, making it a more biodegradable alternative to synthetic polymers.
• Stealth Properties: The steric hindrance generated by the methylated backbone minimizes protein interactions, reducing opsonization and prolonging circulation time in vivo.
• Tunable Chain Lengths: Polysarcosine can be synthesized with precise molecular weights, allowing for tailored hydrodynamic properties and optimized performance in lipid formulations.

Polysarcosine Immunogenicity

One of the most critical advantages of polysarcosine over conventional hydrophilic coatings, such as PEG, is its exceptionally low immunogenicity. Several studies have demonstrated:

• Absence of Anti-pSar Antibodies: Unlike PEG, which can elicit anti-PEG antibodies leading to accelerated blood clearance (ABC effect), polysarcosine does not provoke a significant immune response.
• Minimal Complement Activation: Polysarcosine-modified nanoparticles exhibit negligible complement activation, reducing the risk of immune recognition and clearance.
• Enhanced Biocompatibility: Due to its peptidomimetic nature, polysarcosine seamlessly integrates with biological systems without triggering adverse immune reactions.

These features make polysarcosine an attractive alternative for repeated administrations in therapeutic applications, including gene therapy, targeted drug delivery, and vaccine development.

What are Polysarcosine (pSar) Lipids?

Polysarcosine lipids (pSar lipids) are a novel class of amphiphilic molecules that incorporate polysarcosine as a hydrophilic polymer chain in lipid-based delivery systems. These specialized lipids are designed to improve the stability, circulation time, and bioavailability of nanocarriers, such as lipid nanoparticles (LNPs) and liposomes.

Key Features of pSar Lipids

• Hydrophilic Shell: The polysarcosine segment forms a protective hydrophilic corona, reducing aggregation and preventing protein adsorption.
• Enhanced Pharmacokinetics: Prolonged systemic circulation due to reduced immune clearance.
• Improved Cellular Uptake: Facilitates efficient endocytosis while minimizing non-specific interactions.
• Biodegradability: Natural degradation pathways enhance safety and clearance from the body.

Advantages of Polysarcosine Lipids

Polysarcosine (pSar) lipids represent a groundbreaking advancement in lipid-based drug delivery, offering significant advantages over conventional polymer-lipid conjugates like polyethylene glycol (PEG). These benefits make pSar lipids a superior choice for enhancing the stability, circulation, and biocompatibility of nanocarriers in various therapeutic applications.

Extended Circulation Time and Stealth Properties

Polysarcosine lipids form a hydrophilic and sterically protective shell around lipid nanoparticles (LNPs) and liposomes, reducing interactions with plasma proteins and immune system components. This results in:

• Reduced Opsonization: Prevents rapid recognition and clearance by macrophages and the mononuclear phagocyte system (MPS).
• Longer Half-Life: Prolongs nanoparticle circulation in the bloodstream, improving drug bioavailability and therapeutic efficiency.
• Efficient Tumor Targeting: Enhances passive accumulation in tumor tissues via the enhanced permeability and retention (EPR) effect.

Non-Immunogenic and Non-Toxic

One of the major drawbacks of PEGylation is the induction of anti-PEG antibodies, leading to the accelerated blood clearance (ABC) effect and reduced drug efficacy in subsequent doses. In contrast, pSar lipids offer:

• No Detectable Anti-pSar Antibodies: Enabling safe and repeated administration without loss of efficacy.
• Minimal Complement Activation: Avoids immune-triggered nanoparticle clearance, improving systemic retention.
• Superior Biocompatibility: As a peptidomimetic polymer, polysarcosine is naturally metabolized without causing toxic accumulation.

Improved Cellular Uptake and Endosomal Escape

Efficient intracellular delivery is crucial for nucleic acid-based therapeutics such as mRNA, siRNA, and gene-editing tools. pSar lipids enhance:

• Targeted Endocytosis: Facilitates receptor-mediated uptake by cells, increasing intracellular drug delivery.
• Endosomal Escape: Improves cytoplasmic release of encapsulated cargo, ensuring higher transfection efficiency in gene therapy applications.

Enhanced Stability and Formulation Flexibility

Polysarcosine lipids provide superior formulation stability by preventing nanoparticle aggregation and degradation. This results in:

• Better Long-Term Storage Stability: Maintains lipid nanoparticle integrity over extended periods.
• Resistance to Enzymatic Degradation: Ensures sustained drug release and prolonged therapeutic effects.
• Customizable Chain Lengths and Architectures: Enables precise tuning of lipid properties for specific drug delivery applications.

Applications of Our Self-Adjuvanted Liposome Vaccine Development Service

Polysarcosine (pSar) lipids are revolutionizing lipid-based drug delivery systems by offering superior biocompatibility, non-immunogenicity, and extended circulation time. Their unique properties make them highly effective across a wide range of biomedical and pharmaceutical applications, particularly in gene therapy, RNA-based drugs, vaccine development, and targeted drug delivery.

Lipid Nanoparticles (LNPs) for mRNA and siRNA Delivery

Polysarcosine lipids have emerged as a next-generation stealth polymer in lipid nanoparticles (LNPs), which are essential for delivering nucleic acid-based therapies.

• mRNA Vaccines: pSar lipids improve the stability and circulation time of LNP-encapsulated mRNA, ensuring efficient delivery to target cells. This is particularly crucial for vaccines such as those for infectious diseases (e.g., COVID-19, influenza) and cancer immunotherapy.
• siRNA and RNAi Therapy: Enhances the systemic circulation of RNA-based drugs, improving gene silencing efficiency by preventing rapid degradation and immune activation.

Non-Immunogenic Liposomes for Drug Delivery

Liposomes modified with polysarcosine lipids exhibit improved pharmacokinetics and reduced clearance by the mononuclear phagocyte system (MPS).

• Chemotherapeutic Drug Delivery: pSar-coated liposomes extend the circulation time of cytotoxic drugs like doxorubicin and paclitaxel, improving tumor accumulation via the enhanced permeability and retention (EPR) effect.
• Anti-Inflammatory and Immunosuppressive Drugs: Polysarcosine-modified liposomes improve the targeted delivery of drugs for autoimmune diseases, inflammatory disorders, and organ transplantation therapy.

Gene Therapy and CRISPR-Cas9 Delivery

Polysarcosine lipids enhance the delivery of gene-editing tools such as CRISPR-Cas9 and DNA-based therapies.

• Efficient Endosomal Escape: Ensures successful cytoplasmic release of nucleic acids for gene modification.
• Targeted Cell Uptake: pSar-modified lipid carriers enable selective delivery of gene-editing components to specific tissues or tumor sites.

Polysarcosine-Based Micelles for Hydrophobic Drug Delivery

Hydrophobic drugs suffer from poor solubility and bioavailability, but polysarcosine-based polymeric micelles offer a highly stable and biocompatible platform for their delivery.

• Cancer Therapy: Increases the solubility of poorly water-soluble drugs such as paclitaxel, curcumin, and camptothecin, enhancing their therapeutic efficacy.
• Neurodegenerative Disease Treatments: pSar-modified micelles improve the blood-brain barrier (BBB) penetration of drugs for conditions like Alzheimer's and Parkinson's disease.

Next-Generation Vaccine Delivery Systems

Polysarcosine lipids are a promising alternative to PEGylation in vaccine formulations, providing longer circulation time and enhanced immune response modulation.

• Protein and Peptide Vaccines: pSar-coated nanocarriers improve antigen stability and sustained release, leading to stronger and longer-lasting immune responses.
• DNA and RNA Vaccines: Enables enhanced intracellular delivery of genetic vaccines, reducing degradation and increasing expression levels.

Theranostics and Imaging Agents

Polysarcosine-functionalized nanoparticles are widely explored in diagnostic imaging and theranostics, where simultaneous therapy and imaging are required.

• Tumor Imaging and Targeting: pSar-modified liposomes and nanoparticles improve the specificity of imaging agents in MRI, PET, and fluorescence-based imaging.
• Contrast Agents for Cardiovascular and Neurological Disorders: Polysarcosine-coated nanoparticles enhance the blood-brain barrier penetration of contrast agents, aiding in the diagnosis of neurological diseases.

Why Choose Polysarcosine (pSar) Lipids from BOC Sciences?

At BOC Sciences, we specialize in providing high-quality, customizable polysarcosine lipids for cutting-edge drug delivery applications. Our expertise in polymer-lipid conjugation, lipid nanoparticle formulation, and advanced biocompatible materials ensures that our pSar lipids meet the most rigorous scientific and industrial standards.

• High-Purity, Customizable pSar Lipids: We offer precisely engineered polysarcosine lipids with tunable chain lengths, lipid anchor modifications, and functionalized derivatives to optimize drug formulation performance.
• Comprehensive Quality Control and Characterization: Our pSar lipids undergo rigorous quality control, including HPLC, NMR, and mass spectrometry analysis, ensuring batch-to-batch consistency and superior purity.
• Expert Support and Formulation Assistance: Our team of lipid formulation specialists and polymer chemists provides comprehensive support, from initial research to final application, helping you optimize your drug delivery system for maximum efficacy.
• Scalable Manufacturing for Research and Commercialization: From small-scale R&D synthesis to large-scale GMP production, we ensure a seamless supply chain for all your polysarcosine lipid needs.
• Cutting-Edge Innovation in Lipid-Based Drug Delivery: BOC Sciences remains at the forefront of biocompatible lipid technologies, continuously optimizing our polysarcosine-based solutions to meet the evolving demands of nanomedicine and therapeutic development.

With BOC Sciences' high-quality pSar lipids, researchers and pharmaceutical developers can achieve enhanced drug delivery performance, reduced immunogenicity, and improved patient outcomes. Contact us today to discuss how our polysarcosine lipids can accelerate your next-generation therapeutic formulations.